Center for Common Disease Genomics [CCDG] - Neuropsychiatric: Epilepsy: Epi25 Consortium
Demographics (2)
- SEX - Gender of participant (phv00396837.v2.p2)
- SEX - Sex (phv00528324.v1.p2)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject (phv00528325.v1.p2)
Geography (1)
- SITE - Site where sequencing occurred (phv00396841.v2.p2)
Race and Ethnicity (1)
- RACE - Reported race of participant (phv00396843.v2.p2)
Other (15)
- ANALYSIS_CAT - Analysis category (phv00396839.v2.p2)
- ANALYTE_TYPE - Analyte type (phv00396846.v2.p2)
- BODY_SITE - Body site where samle was collected (phv00396845.v2.p2)
- CONSENT - Consent group as determined by DAC (phv00396829.v2.p2)
- Coverage_Pass - Samples meeting 85% of targets at 20X coverage (phv00396842.v2.p2)
- EPILEPSY_TYPE - Epilepsy type (phv00396840.v2.p2)
- IS_TUMOR - Tumor status (phv00396847.v2.p2)
- PRIMARY_DISEASE - Primary disease of participant (phv00396838.v2.p2)
- SAMPLE_ID - De-identified Sample ID (phv00396844.v2.p2)
- SAMPLE_ID - Sample ID (phv00396832.v2.p2)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00420448.v1.p2)
- SUBJECT_ID - De-identified subject ID (phv00396836.v2.p2)
- SUBJECT_ID - Subject ID (phv00396828.v2.p2)
- SUBJECT_ID - Subject ID (phv00396831.v2.p2)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00420447.v1.p2)